Now I have all the information I need. Let me produce the consolidated review.

## Summary

This paper introduces the Sequential Multiple Instance Learning (SMIL) framework, which explicitly models the temporal ordering of clinical images — a dimension largely ignored by prior MIL work that treats images as unordered bags. The authors propose BiSMIL, a bidirectional Transformer architecture with a novel weighted incremental training loss that encourages accurate predictions from partial subsequences while maintaining high final accuracy. They also introduce SMILU, an uncertainty metric leveraging sequential prediction variability. Experiments on three medical imaging datasets (UTD, RSNA, SARS-CoV-2 CT) show BiSMIL achieves state-of-the-art final accuracy and can match baseline performance with 30–50% fewer images.

## Strengths

1. **Novel problem framing with practical significance.** The SMIL framework formalizes an underexplored but clinically important setting — sequential clinical imaging where the number of images per patient varies and only a single diagnostic label is available at the bag level. The tradeoff between early accuracy (reducing radiation/time) and final accuracy is well-motivated (Section 1, Section 3.1). The paper demonstrates concrete efficiency gains: on the UTD dataset, BiSMIL with 50% of images matches ADMIL's accuracy with 100% (Figure 4).

2. **State-of-the-art final accuracy across three datasets.** Table 1 shows BiSMIL consistently outperforms SA-DMIL, MaxPool, ADMIL, and its own unidirectional variant (SiSMIL) on Accuracy, Precision, Recall, and F1 across all three datasets, often with statistical significance at the 95% level. The inclusion of SiSMIL provides a clean ablation showing that bidirectionality contributes meaningful gains beyond the architecture alone.

3. **Novel training procedure for a genuinely hard problem.** The weighted incremental loss (Equation 3) is a thoughtful design that addresses the core challenge: subsequence labels are unavailable, and naively applying the bag label uniformly would distort early predictions. The softmax weighting scheme that down-weights shorter subsequences is a principled compromise between using available supervision and not over-penalizing early predictions (Section 3.3). The hybrid loss (combining BCE on full sequences with WIL on subsequences) is a reasonable approach to balancing early and final accuracy.

4. **Multi-dataset validation with statistical reporting.** Results are averaged over 5 independent trials with standard deviations and 95% confidence bands reported (Table 1, Figure 4). The use of three distinct medical imaging modalities (ultrasound, brain CT, lung CT) supports generalizability claims.

## Weaknesses

### Fatal
None.

### Major

1. **The central claim of "faithful" subsequence-level predictions is not directly validated, and the evaluation of early accuracy relies on the same bag-level labels the paper acknowledges are inappropriate for subsequences.** The paper states in Section 3.1 that "the bag-level label might not be correct for the subsequence" and that it is "insufficient to directly utilize the sequence-level label as a stand-in for the labels of individual subsequences." Yet the primary evidence for early prediction accuracy (Figure 4) compares each subsequence prediction against the bag-level label. This creates a tension: if a positive bag's evidence appears only in the final images, an early negative prediction is clinically correct for that subsequence but counted as an error. Conversely, a model trained to predict positive from insufficient evidence would be counted as "correct." The paper acknowledges this issue in motivation but never provides an evaluation protocol that disentangles faithfulness to subsequence-level truth from early prediction of the bag label. While predicting the final diagnosis from fewer images is itself clinically useful — and the Figure 4 comparison is meaningful for that purpose — the paper's stated goal of "faithful to the (unobserved) subsequence labels" (Section 3.3, line 82) remains unsubstantiated. Some qualitative clinician validation is mentioned (Section 3.1, "evaluation from a clinician, who stated that only these three images showed any signs of abnormality"), but this is anecdotal rather than a systematic evaluation.

2. **The SMILU uncertainty metric is validated against only a single baseline (entropy), with unspecified weights.** The paper claims SMILU "outperforms common metrics" (Section 5.3, Figure 3b), but the only comparison is against entropy and random removal. Entropy is a reasonable baseline, but the claim of superiority would be stronger with comparisons to predictive variance, Monte Carlo dropout uncertainty, or the model's own softmax confidence. Additionally, the weights $w_s$ and $w_o$ in Equation 6 are not reported — the paper says "the weights can vary depending on the particular application" (line 153) without stating what values were used in the experiments or how they were selected. This makes the result difficult to reproduce or interpret.

### Minor

1. **No ablation separating the training procedure from the architecture.** Figure 4 shows BiSMIL dominates baselines on early prediction, but the baselines were not designed or trained for early prediction (they use their original hyperparameters and objectives, as stated in Section 5.1). This makes it unclear how much of the gain comes from the weighted incremental loss vs. the bidirectional Transformer architecture itself. An ablation comparing BiSMIL trained with vs. without the weighted incremental loss, or comparing a baseline (e.g., ADMIL) fine-tuned with the same loss, would isolate the source of improvement. The SiSMIL ablation partially addresses architectural questions but does not disentangle architecture from training objective for early prediction.

2. **Inference procedure for combining bidirectional predictions is underspecified.** The paper describes that during inference, the front and reverse directions each produce a prediction (Algorithm 2, partially visible), but it does not state how $p_{il}^f$ and $p_{il}^r$ are combined into a single $p_{il}$. Are they averaged? Concatenated and passed through a final layer? This is a reproducibility gap.

3. **Feature extractor backbone is not specified.** The paper refers only to "convolutional layers" (Section 3.2, line 67) without specifying the architecture (ResNet? DenseNet? Custom?), pretraining details, image preprocessing (beyond the RSNA-specific windowing), or any data augmentation. This information is essential for reproducibility.

4. **Position encoding components are not ablated.** The position encoding combines linear and Gaussian embeddings (Section 3.2). No experiment demonstrates that the Gaussian component provides benefit over linear alone, or that the design is robust to reversal as claimed.

5. **SMILU's two components ($\mathcal{S}$ and $\mathcal{O}$) are not analyzed separately.** The paper does not show the relative contribution of sequence dispersion vs. output uncertainty to the overall SMILU metric, nor whether both components are necessary.

### Trivial
None.

## Nice-to-Haves

- **Statistical testing for differences in incremental prediction curves (Figure 4).** The paper shows confidence bands but does not report whether differences between BiSMIL and baselines at specific subsequence lengths are statistically significant.
- **Obtaining a small held-out set of subsequence-level labels** (e.g., 200–300 subsequences from a radiologist) would directly validate the faithfulness claim.
- **Analysis of the relationship between attention weights and incremental predictions / SMILU scores.** Figure 3(a) marks the highest-attention image but does not quantify the connection.

## Removed Points

These points are flagged to be removed; treat them with caution.

- **BCE equation typo (y_i appears twice):** The reviewer noted that Equation 3 has $y_i\log(1-p)$ instead of $(1-y_i)\log(1-p)$. This is almost certainly a PDF extraction/formatting artifact — the paper's results would be impossible with a broken loss function for negative bags. Per parser-error policy, this is removed.
- **Weighting scheme "contradicting" early prediction goal:** The reviewer argued the softmax weights down-weight early subsequences too much, contradicting the goal. However, this is by design — the weights soften rather than eliminate early-subsequence supervision, and the paper explicitly states this addresses the problem that early subsequences may not have seen key evidence. The criticism reflects a misunderstanding of the design rationale.
- **"The paper never returns to this problem during evaluation" (Section 1 criticism):** This is a restatement of the main evaluation concern already captured in Major Weakness 1.
- **"If the original paper contains this error" speculation about BCE:** Removed per parser-error policy.
- **Missing related works:** Per instructions, I cannot confirm the existence of related works I don't have access to.
- **Code release not mentioned:** This is standard for conference submissions and not a weakness per se; many papers release code post-acceptance.
- **Strength Finder's generic strengths** (e.g., "Thorough evaluation on three real-world medical datasets" which is partially redundant with listed strengths, and "Clinically motivated interpretability" which is vague and conflicts with the validated weakness about SMILU's limited validation) have been merged into the main strengths or removed.

## Novel Insights

None beyond the paper's own contributions. The reviews do not surface a novel observation that the paper itself does not already make.

## Suggestions

1. **Clarify the evaluation narrative.** Explicitly state that Figure 4 measures early accuracy of *bag-label prediction* (a clinically meaningful metric), and separate this from the "faithfulness to subsequence truth" claim. Either reframe the faithfulness claim or provide direct validation (e.g., a small set of subsequence-level labels from a clinician).
2. **Ablate the training procedure from the architecture.** Compare BiSMIL with full loss vs. BiSMIL with BCE-only on full sequences, and/or compare a baseline (ADMIL) fine-tuned with the weighted incremental loss.
3. **Report the SMILU weights $w_s$ and $w_o$** used in experiments.
4. **Add more uncertainty baselines** (e.g., softmax confidence, MC dropout variance) to Figure 3(b).
5. **Specify the feature extractor backbone**, image preprocessing, and how bidirectional predictions are combined during inference.
6. **Ablate the position encoding components** (linear vs. Gaussian vs. both).

## Score and Decision

This paper addresses a genuine problem — sequential clinical imaging with bag-level labels — and proposes a well-motivated framework, architecture, and training procedure. The core empirical results (state-of-the-art final accuracy across three datasets, clinically meaningful early-prediction gains) are solid and supported by statistical reporting. However, the main weakness is a gap between the paper's claim of "faithful" subsequence-level predictions and an evaluation that necessarily relies on bag-level labels as a proxy. This does not invalidate the core contribution (early bag-label prediction is itself clinically important and is what Figure 4 measures), but it means one of the paper's stated goals remains unverified. The SMILU validation is thin, and several ablation and reproducibility details are missing. These are addressable issues, and the paper's core ideas represent a meaningful advance.

MY FINAL SCORE: <pineapple>6.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>